Currently holds positions in Air Products and Chemicals Inc, Amicus Therapeutics Inc and Vertex Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Independent Director | Air Products and Chemicals Inc | March 17, 2005 - |
Independent Director | Amicus Therapeutics Inc | Oct. 1, 2009 - |
Independent Director | Vertex Pharmaceuticals Inc | May 1, 2011 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-03-06 | 2024-03-05 |
Amicus Therapeutics Inc
(FOLD)
|
S Sale |
7,500
-11.2%
13.40100,500 USD |
7,500 -11.2% | 13.40 | 100,500 USD | |
2024-03-06 | 2024-03-04 |
Amicus Therapeutics Inc
(FOLD)
|
S Sale |
7,500
-11.2%
13.2999,675 USD |
7,500 -11.2% | 13.29 | 99,675 USD | |
2023-01-17 | 2023-01-13 |
Amicus Therapeutics Inc
(FOLD)
|
PS Planned sale |
15,000
-22.8%
13.03195,387 USD |
15,000 -22.8% | 13.03 | 195,387 USD | |
2022-05-04 | 2022-05-02 |
Amicus Therapeutics Inc
(FOLD)
|
PS Planned sale |
15,000
-28.3%
6.99104,897 USD |
15,000 -28.3% | 6.99 | 104,897 USD | |
2022-04-12 | 2022-04-08 |
Vertex Pharmaceuticals Inc
(VRTX)
|
PS Planned sale |
100
-8.3%
281.4928,149 USD |
100 -8.3% | 281.49 | 28,149 USD | |
2022-04-12 | 2022-04-08 |
Vertex Pharmaceuticals Inc
(VRTX)
|
PS Planned sale |
4,900
-80.3%
280.191,372,931 USD |
4,900 -80.3% | 280.19 | 1,372,931 USD | |
2022-04-04 | 2022-03-31 |
Vertex Pharmaceuticals Inc
(VRTX)
|
PS Planned sale |
1,011
-47.9%
262.97265,863 USD |
1,011 -47.9% | 262.97 | 265,863 USD | |
2022-04-04 | 2022-03-31 |
Vertex Pharmaceuticals Inc
(VRTX)
|
PS Planned sale |
2,970
-58.5%
262.37779,239 USD |
2,970 -58.5% | 262.37 | 779,239 USD | |
2022-04-04 | 2022-03-31 |
Vertex Pharmaceuticals Inc
(VRTX)
|
PS Planned sale |
1,019
-16.7%
261.28266,244 USD |
1,019 -16.7% | 261.28 | 266,244 USD | |
2022-02-01 | 2022-01-28 |
Vertex Pharmaceuticals Inc
(VRTX)
|
PS Planned sale |
212
-16.2%
243.2451,567 USD |
212 -16.2% | 243.24 | 51,567 USD | |
2022-02-01 | 2022-01-28 |
Vertex Pharmaceuticals Inc
(VRTX)
|
PS Planned sale |
2,087
-61.4%
242.78506,682 USD |
2,087 -61.4% | 242.78 | 506,682 USD | |
2022-02-01 | 2022-01-28 |
Vertex Pharmaceuticals Inc
(VRTX)
|
PS Planned sale |
800
-19.1%
241.83193,464 USD |
800 -19.1% | 241.83 | 193,464 USD | |
2022-02-01 | 2022-01-28 |
Vertex Pharmaceuticals Inc
(VRTX)
|
PS Planned sale |
1,901
-31.2%
240.53457,248 USD |
1,901 -31.2% | 240.53 | 457,248 USD | |
2020-04-20 | 2020-04-17 |
Amicus Therapeutics Inc
(FOLD)
|
PS Planned sale |
10,000
-31.2%
11.00110,000 USD |
10,000 -31.2% | 11.00 | 110,000 USD | |
2020-01-10 | 2020-01-09 |
Amicus Therapeutics Inc
(FOLD)
|
PS Planned sale |
20,000
-47.5%
10.00200,000 USD |
20,000 -47.5% | 10.00 | 200,000 USD | |
2019-10-24 | 2019-10-22 |
Vertex Pharmaceuticals Inc
(VRTX)
|
PS Planned sale |
20,000
-82.9%
190.003,800,000 USD |
20,000 -82.9% | 190.00 | 3,800,000 USD | |
2004-02-04 | 2004-02-03 |
Merck & Co Inc
(MRK)
|
B Purchase |
2,500
+55.6%
48.00120,000 USD |
2,500 +55.6% | 48.00 | 120,000 USD |